» Articles » PMID: 19904830

Excision of Reprogramming Transgenes Improves the Differentiation Potential of IPS Cells Generated with a Single Excisable Vector

Overview
Journal Stem Cells
Date 2009 Nov 12
PMID 19904830
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

The residual presence of integrated transgenes following the derivation of induced pluripotent stem (iPS) cells is highly undesirable. Here we demonstrate efficient derivation of iPS cells free of exogenous reprogramming transgenes using an excisable polycistronic lentiviral vector. A novel version of this vector containing a reporter fluorochrome allows direct visualization of vector excision in living iPS cells in real time. We find that removal of the reprogramming vector markedly improves the developmental potential of iPS cells and significantly augments their capacity to undergo directed differentiation in vitro. We further propose that methods to efficiently excise reprogramming transgenes with minimal culture passaging, such as those demonstrated here, are critical since we find that iPS cells may acquire chromosomal abnormalities, such as trisomy of chromosome 8, similar to embryonic stem cells after expansion in culture. Our findings illustrate an efficient method for the generation of transgene-free iPS cells and emphasize the potential beneficial effects that may result from elimination of integrated reprogramming factors. In addition, our results underscore the consequences of long-term culture that will need to be taken into account for the clinical application of iPS cells.

Citing Articles

Generation of human alveolar epithelial type I cells from pluripotent stem cells.

Burgess C, Huang J, Bawa P, Alysandratos K, Minakin K, Ayers L Cell Stem Cell. 2024; 31(5):657-675.e8.

PMID: 38642558 PMC: 11147407. DOI: 10.1016/j.stem.2024.03.017.


Generation of iPSCs Using Sendai Virus Vectors.

Aoki H Methods Mol Biol. 2024; 2794:121-140.

PMID: 38630225 DOI: 10.1007/978-1-0716-3810-1_11.


An Alternate Approach to Generate Induced Pluripotent Stem Cells with Precise CRISPR/Cas9 Tool.

Javaid N, Choi S Stem Cells Int. 2022; 2022:4537335.

PMID: 36187228 PMC: 9522500. DOI: 10.1155/2022/4537335.


A real-time pluripotency reporter for the long-term and real-time monitoring of pluripotency changes in induced pluripotent stem cells.

Shen H, Li Y, Huang S, Xia J, Yao Z, Xiao G Aging (Albany NY). 2022; 14(10):4445-4458.

PMID: 35575836 PMC: 9186763. DOI: 10.18632/aging.204083.


Elimination of Reprogramming Transgenes Facilitates the Differentiation of Induced Pluripotent Stem Cells into Hepatocyte-like Cells and Hepatic Organoids.

Jeong J, Kim T, Kim M, Jung Y, Kim K, Shim S Biology (Basel). 2022; 11(4).

PMID: 35453693 PMC: 9030920. DOI: 10.3390/biology11040493.


References
1.
Wernig M, Lengner C, Hanna J, Lodato M, Steine E, Foreman R . A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol. 2008; 26(8):916-24. PMC: 2654269. DOI: 10.1038/nbt1483. View

2.
Sridharan R, Tchieu J, Mason M, Yachechko R, Kuoy E, Horvath S . Role of the murine reprogramming factors in the induction of pluripotency. Cell. 2009; 136(2):364-77. PMC: 3273494. DOI: 10.1016/j.cell.2009.01.001. View

3.
Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

4.
Meissner A, Mikkelsen T, Gu H, Wernig M, Hanna J, Sivachenko A . Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008; 454(7205):766-70. PMC: 2896277. DOI: 10.1038/nature07107. View

5.
Soldner F, Hockemeyer D, Beard C, Gao Q, Bell G, Cook E . Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009; 136(5):964-77. PMC: 2787236. DOI: 10.1016/j.cell.2009.02.013. View